AR090095A1 - Preparacion farmaceutica que comprende hormona estimulante del foliculo recombinante - Google Patents

Preparacion farmaceutica que comprende hormona estimulante del foliculo recombinante

Info

Publication number
AR090095A1
AR090095A1 ARP120101991A ARP120101991A AR090095A1 AR 090095 A1 AR090095 A1 AR 090095A1 AR P120101991 A ARP120101991 A AR P120101991A AR P120101991 A ARP120101991 A AR P120101991A AR 090095 A1 AR090095 A1 AR 090095A1
Authority
AR
Argentina
Prior art keywords
stimulating hormone
folicle
recombinant
pharmaceutical preparation
includes stimulating
Prior art date
Application number
ARP120101991A
Other languages
English (en)
Inventor
Rikard Lorentz Sandstrm Bjrn
Cottingham Ian
Plaksin Daniel
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of AR090095A1 publication Critical patent/AR090095A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/59Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Preparaciones que incluyen HEF (Hormona estimulante del folículo), por ejemplo HEF recombinada, en donde 17% a 23% de las estructuras glicano sialiladas son estructuras glicano tetra-sialiladas. Hormona estimulante del folículo. Método de tratamiento.
ARP120101991A 2011-06-06 2012-06-06 Preparacion farmaceutica que comprende hormona estimulante del foliculo recombinante AR090095A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11168816 2011-06-06

Publications (1)

Publication Number Publication Date
AR090095A1 true AR090095A1 (es) 2014-10-22

Family

ID=46397316

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120101991A AR090095A1 (es) 2011-06-06 2012-06-06 Preparacion farmaceutica que comprende hormona estimulante del foliculo recombinante

Country Status (3)

Country Link
EP (1) EP2717904A1 (es)
AR (1) AR090095A1 (es)
WO (1) WO2012168680A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
US20180264086A1 (en) * 2015-09-17 2018-09-20 Glycotope Gmbh Mammalian follicle-stimulating hormone composition with increased stability
IL272763B2 (en) 2017-09-01 2024-02-01 Ferring Bv The composition for controlled stimulation of the ovary

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MEP38608A (en) * 2001-10-22 2011-02-10 Merck Serono Sa Gonadotrophins for folliculogenesis
US8609370B2 (en) * 2004-02-13 2013-12-17 Glycotope Gmbh Highly active glycoproteins-process conditions and an efficient method for their production
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
TWI532495B (zh) * 2009-10-05 2016-05-11 菲瑞茵國際中心股份有限公司 藥學製劑
WO2012016576A1 (en) 2010-08-04 2012-02-09 Glycotope Gmbh Improved recombinant human follicle-stimulating hormone

Also Published As

Publication number Publication date
EP2717904A1 (en) 2014-04-16
WO2012168680A1 (en) 2012-12-13
WO2012168680A8 (en) 2014-01-03

Similar Documents

Publication Publication Date Title
JO3357B1 (ar) مركبات إيميدازوبيروليدينون
PH12016501966A1 (en) Compounds and compositions as toll-like receptor 7 agonists
MX2017016376A (es) Derivado de piperidina y metodo de preparacion y uso farmaceutico del mismo.
CR20160564A (es) Dinucleótidos cíclicos como moduladores de sting
NZ629996A (en) 2’- substituted carba-nucleoside analogs for antiviral treatment
MY188139A (en) Sodium channel modulators for the treatment of pain
UY34101A (es) Proteínas de unión a antígeno
BR112017005202A2 (pt) anticorpos anti-met e composições
CY1119957T1 (el) Θεραπεια νοσηματων με τη χρηση ανοχογονου φαρμακευτικου παρασκευασματος
DOP2014000059A (es) Derivados de estra–1,3,5(10),16–tetraen–3–carboxamida, procedimientos para su preparación, preparados farmacéuticos que los contienen, así como su uso para la preparación de medicamentos
UY35906A (es) Novedosos derivados de bencimidazol como ligandos de ep4
MX2018000264A (es) Formulaciones topicas de diacereina de rheina y sus usos.
EA201690191A1 (ru) Фармацевтическая композиция для замедленного высвобождения ланреотида
EA201792571A1 (ru) Терапевтическое применение l-4-хлорокинуренина
MX2017013564A (es) Formulaciones de glucopiranosil lipido a y alérgenos de cacahuete para administración sublingual.
PH12017501735A1 (en) Novel heterocyclic compound, method for preparing the same, and pharmaceutical composition comprising the same
CL2014003443A1 (es) Compuestos derivados de n-[4-(quinolin-4-iloxi)ciclohexil(metil)](hetero)aril-carboxamidas; su metodo de produccion; compuestos intermediarios; producto medicinal que contiene al compuesto, util para el tratamiento y/o prevencion de enfermedades hiperproliferativas, las cuales son dependientes del receptor de androgenos.
PH12014502065A1 (en) Vesicular formulations
AR090095A1 (es) Preparacion farmaceutica que comprende hormona estimulante del foliculo recombinante
WO2015057836A3 (en) Bone anabolic parathyroid hormone and parathyroid hormone related-protein analogs
MX364528B (es) Witanólidos útiles para el tratamiento de enfermedades neurodegenerativas.
MX2016005645A (es) Composicion farmaceutica topica de acitretina.
MX2015016283A (es) METODOS PARA TRATAR AFECCIONES INFLAMATORIAS UTILIZANDO S-[4-(3-FLUORO-3-METILBUTIRILOXI) BUT-2-INIL] 6A, 9A-DIFLUORO-17A- (FURAN-2-IL) CARBONILOXI-11ß-HIDROXI-16A - METIL-3-OXOANDROSTA-1,4-DIEN-17ß - CARBOTIOATO.
EA201291384A1 (ru) Терапевтические агенты 976
EA201892675A1 (ru) Фармацевтическая композиция, содержащая этеплирсен

Legal Events

Date Code Title Description
FB Suspension of granting procedure